Led by Joel Roodman, the company titled Mus immersive aims "to realize the full potential of the theatrical immersive window." By Georg Szalai Global Business Editor A new startup, MUS immersive ...

While factors for disease, such as genetic risk, have been extensively identified, their presence alone does not determine progression to disease. To understand what’s driving oncogenesis across ...

Spatial biology is a rapidly advancing discipline that examines biological molecules (such as DNA, RNA, and proteins) within their native locations in tissues. This approach offers critical insight ...

Researchers have created a detailed map of a deadly childhood cancer, showing it uses "shields" and "bodyguards" to protect itself, paving the way for new treatments. The team's paper, titled "Spatial ...

For years, Susan watched her two children collapse without warning. Episodes of sudden, full-body muscle weakness that came and went — sometimes lasting minutes, sometimes hours. Between episodes, ...

Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years. Though ...

The origin of many diseases begins at the cellular level and involves multiple molecular interactions. However, previous methods have struggled to accurately observe changes in individual cells.

A group of a few dozen colorful translucent 3D blobs, many of which overlap, contain brightly colored dots against a black background. Three-dimensional transcriptomics data from an instrument ...

SAN DIEGO, Feb. 26, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and proteomics ...

Most people alive today carry fragments of Neanderthal DNA in their genome. Now scientists are gaining a more intimate understanding of the ancient encounters that put it there. By Carl Zimmer One of ...

At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Illumina, Inc. (ILMN) today announced new customer ...